<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01057381</url>
  </required_header>
  <id_info>
    <org_study_id>H-17558</org_study_id>
    <nct_id>NCT01057381</nct_id>
  </id_info>
  <brief_title>Dexmedetomidine in Pediatric Tonsillectomy</brief_title>
  <official_title>Dose Response Relationship of Dexmedetomidine in Decreasing Post Operative Analgesic Requirements in the Pediatric Tonsillectomy Patient</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Baylor College of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Baylor College of Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The hypothesis of this study is that the administration of an intra-operative dose of
      dexmedetomidine will result in adequate analgesia without respiratory depression thereby
      resulting in an early discharge from the post anesthetic care unit following
      adenotonsillectomy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Dexmedetomidine, an alpha 2 agonist provides some analgesia without respiratory depression.
      Children undergoing tonsillectomy and adenoidectomy occasionally have episodes of respiratory
      obstruction in the recovery room following administration of opioids.

      As dexmedetomidine provides some analgesia without respiratory depression,an intra-operative
      dose of dexmedetomidine may provide adequate analgesia without significant side effects
      thereby allowing for quick post operative recovery.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2005</start_date>
  <completion_date type="Actual">December 2010</completion_date>
  <primary_completion_date type="Actual">November 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>opioid sparing effect of dexmedetomidine following adenotonsillectomy</measure>
    <time_frame>First hour following adenotonsillectomy</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Degree of sedation</measure>
    <time_frame>Over the first hour following surgery</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">109</enrollment>
  <condition>Pediatric Adenotonsillectomy</condition>
  <condition>Post Operative Analgesia</condition>
  <arm_group>
    <arm_group_label>Dexmedetomidine 0.75 mcg/kg</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intraoperative administration for analgesia.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dexmedetomidine 1mcg/kg</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intra-operative administration of dexmedetomidine 1 mcg/kg for analgesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Morphine 50 mcg/kg</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intra-operative administration of morphine 50 mcg/kg for analgesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Morphine 100mcg/kg</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intra-operative administration of morphine 100mcg/kg for analgesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine 0.75 mcg/kg</intervention_name>
    <description>Single intra-operative administration of dexmedetomidine 0.75 mcg/kg over 10 minutes for analgesia.</description>
    <arm_group_label>Dexmedetomidine 0.75 mcg/kg</arm_group_label>
    <other_name>Precedex</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Morphine 50 mcg/kg</intervention_name>
    <description>Single intra-operative administration of morphine 50 mcg/kg over 10 minutes for analgesia</description>
    <arm_group_label>Morphine 50 mcg/kg</arm_group_label>
    <other_name>Morphine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Morphine 100 mcg/kg</intervention_name>
    <description>Single intra-operative dose of morphine 100 mcg/kg over 10 minutes for analgesia</description>
    <arm_group_label>Morphine 100mcg/kg</arm_group_label>
    <other_name>Morphine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine 1 mcg/kg</intervention_name>
    <description>Single intra-operative administration of dexmedetomidine 1 mcg/kg over 10 minutes for analgesia</description>
    <arm_group_label>Dexmedetomidine 1mcg/kg</arm_group_label>
    <other_name>Precedex</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Children between ages 3 and 17 years with American Society of Anesthesiology
             classification 1 or 2.

        Exclusion Criteria:

          -  Children less than 3 years

          -  Children with uncorrected cardiac lesions

          -  Children with heart block or liver impairment

          -  Children with American Society of Anesthesiology Class 3 or 4.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Olutoyin A Olutoye, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Baylor College of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Texas Children's Hospital, Baylor College of Medicine</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 25, 2010</study_first_submitted>
  <study_first_submitted_qc>January 26, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 27, 2010</study_first_posted>
  <last_update_submitted>August 9, 2012</last_update_submitted>
  <last_update_submitted_qc>August 9, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 10, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Baylor College of Medicine</investigator_affiliation>
    <investigator_full_name>OLUTOYIN A. OLUTOYE</investigator_full_name>
    <investigator_title>Associate Professor of Anesthesiology &amp; Pediatrics</investigator_title>
  </responsible_party>
  <keyword>Adenotonsillectomy</keyword>
  <keyword>Postoperative analgesia</keyword>
  <keyword>Pediatrics</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

